IMMUNOSUPPRESSIVE EFFECTS OF RECOMBINANT INTERFERON-ALPHA DURING LONG-TERM TREATMENT OF CANCER-PATIENTS

被引：0
|
作者：
TEICHMANN, JV
SIEBER, G
LUDWIG, WD
RUEHL, H
机构：
来源：
CANCER | 1989年 / 63卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19890515)63:10<1990::AID-CNCR2820631020>3.0.CO;2-E
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1990 / 1993
页数：4
相关论文
共 50 条
  • [1] THYROID AUTOIMMUNITY AND HYPOTHYROIDISM DURING LONG-TERM TREATMENT WITH RECOMBINANT INTERFERON-ALPHA
    GISSLINGER, H
    GILLY, B
    WOLOSZCZUK, W
    MAYR, WR
    HAVELEC, L
    LINKESCH, W
    WEISSEL, M
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 90 (03): : 363 - 367
  • [2] IMMUNOMODULATION BY LONG-TERM TREATMENT OF CANCER-PATIENTS WITH RECOMBINANT INTERFERON-ALPHA-2 (IFN)
    TEICHMANN, JV
    SIEBER, G
    LUDWIG, WD
    RUEHL, H
    [J]. JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 810 - 810
  • [3] OCCURRENCE OF THYROID AUTOIMMUNITY IN PATIENTS ON LONG-TERM THERAPY WITH RECOMBINANT INTERFERON-ALPHA
    GISSLINGER, H
    WEISSEL, M
    KUHRER, I
    LINKESCH, W
    LUDWIG, H
    [J]. BLUT, 1988, 57 (04): : 225 - 225
  • [4] LONG-TERM TREATMENT OF THE CRYPTOGENIC CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALPHA
    HOPF, U
    MOLLER, B
    KONIG, V
    KUTHER, S
    LOBECK, H
    HUHN, D
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1990, 28 (09): : 453 - 457
  • [5] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    ROSENBLUM, MG
    QUESADA, JR
    SHERWIN, SA
    ITRI, LM
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1677 - 1683
  • [6] EFFECTS OF LONG-TERM TREATMENT OF HUMAN CARCINOMA-CELLS WITH INTERFERON-ALPHA
    BROUTYBOYE, D
    MOGENSEN, KE
    GRESSER, I
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04): : 507 - 514
  • [7] Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors - An antiangiogenic effect?
    Dirix, LY
    Vermeulen, PB
    Fierens, H
    DeSchepper, B
    Corthouts, B
    VanOosterom, AT
    [J]. ANTI-CANCER DRUGS, 1996, 7 (02) : 175 - 181
  • [8] Hypertriglyceridemia during long-term interferon-alpha therapy in a series of hematologic patients
    Sgarabotto, D
    Vianello, F
    Stefani, PM
    Scano, F
    Sartori, R
    Caenazzo, A
    Girolami, A
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (05): : 241 - 244
  • [9] LONG-TERM THERAPY WITH INTERFERON-ALPHA IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    WEHMEIER, A
    MEIERKORD, F
    SCHNEIDER, W
    [J]. BLOOD, 1994, 84 (10) : A58 - A58
  • [10] IMMUNOLOGICAL EFFECTS OF RECOMBINANT INTERFERON-ALPHA-2 IN CANCER-PATIENTS
    HENGST, JCD
    KEMPF, RA
    KANMITCHELL, J
    PHAM, ATH
    GRUNBERG, SM
    KORTES, VL
    MITCHELL, MS
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1983, 2 (06): : 516 - 527
12345